Health
Australia signs agreement for new Covid-19 drug – Pharmaceutical Business Review
Australia has signed an agreement for 300,000 courses of molnupiravir, an antiviral pill that has shown signs of reducing deaths…
Australia has signed an agreement for 300,000 courses of molnupiravir, an antiviral pill that has shown signs of reducing deaths and hospitalisations due to Covid-19.
Being trialled in the US, this drug is yet to gain approval from the regulatory authorities.
…
Continue Reading
-
General23 hours agoIndia to defend ‘red lines’ as fresh tariffs loom
-
General24 hours agoNationals Leader David Littleproud says nuclear power policy ‘sensible’ next step
-
Noosa News22 hours agoColombian Director Simón Mesa Soto’s ‘A Poet’ Is 2025’s Winner of Melbourne International Film Festival’s Bright Horizons Award
-
Business21 hours agoWhy this fantastic blue chip ASX 200 share could rise 20%